- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.08. | Swedish digital therapy firm Mindler buys UK rival | ||
| 20.08. | PTC Therapeutics stung by FDA decision not to approve rare disease drug | ||
| 20.08. | New NHS diabetes strategy could raise GLP-1 drug use | ||
| 20.08. | CSL will slash headcount and hive off vaccine business | ||
| 20.08. | Viking felled by dropout rates in oral obesity drug trial | ||
| 19.08. | NHS cleared to use digital cardiac rehab programmes | ||
| 19.08. | Merck unit gets first EU nod for a desmoid tumour treatment | ||
| 19.08. | Novartis taps Atropos AI for earlier PNH diagnoses | ||
| 19.08. | Court sides with Vanda over FDA's Hetlioz rejection | ||
| 18.08. | Novo Nordisk cuts GLP-1 prices for cash buyers | ||
| 18.08. | Merck has a $2bn flutter on Skyhawk's RNA platform | ||
| 18.08. | Leaked MAHA draft signposts US health reform under Trump | ||
| 18.08. | Tonix ends 16-year hiatus in fibromyalgia treatment | ||
| 18.08. | Novo Nordisk claims first GLP-1 approval in MASH | ||
| 18.08. | Pfizer suffers another hit to its GBT sickle cell portfolio | ||
| 15.08. | RFK Jr revives childhood vaccine task force | ||
| 15.08. | AI could lead to 'golden age' of antibiotics | ||
| 15.08. | FDA clears Precigen's rare tumour immunotherapy | ||
| 15.08. | Trump orders stockpiling of essential medicine ingredients | ||
| 14.08. | Under pressure from Trump, Lilly hikes Mounjaro prices in UK | ||
| 14.08. | NHS cleared to use AZ's Fasenra for rare autoimmune disease | ||
| 14.08. | Artera gets FDA okay for prostate cancer AI | ||
| 14.08. | Vedanta's microbiome therapy for IBD disappoints | ||
| 14.08. | MSD reveals the first details of its job cut plans | ||
| 14.08. | Texas suit claims Lilly bribed providers to prescribe drugs |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .